Toward the universal scoring system in treatment for patients with hepatocellular carcinoma

With great interest, we read the article written by Chan et al. in a recent issue of “Journal of Hepatology”.1 The authors attempted to develop a new set of preoperative and postoperative scoring systems (ERASL) to predict the outcomes of hepatectomy for hepatocellular carcinoma (HCC), using a statistical approach and validating its prognostic utility in a large international co hort. Their preoperative score demonstrated decent statistical discrimination for 2-year recurrence-free survival (RFS) in their external validation cohort (C-index 0.601–0.672).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research